XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.3
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings per Share
Earnings Per Share
For the three months ended September 30
For the nine months ended September 30
(In millions, except per share amounts)2024202320242023
Numerator:
Net income from continuing operations$490 $386 $1,312 $1,202 
Net (income) loss attributable to noncontrolling interests(19)(7)(40)(33)
Net income from continuing operations attributable to GE HealthCare
470 379 1,272 1,169 
Deemed preferred stock dividend of redeemable noncontrolling interest— — — (183)
Net income from continuing operations attributable to GE HealthCare common stockholders
470 379 1,272 986 
Income (loss) from discontinued operations, net of taxes
— (4)— (4)
Net income attributable to GE HealthCare common stockholders$470 $375 $1,272 $982 
Denominator:
Basic weighted-average shares outstanding457 455 456 455 
Dilutive effect of common stock equivalents2 3 2 3 
Diluted weighted-average shares outstanding459 458 459 458 
Basic Earnings Per Share:
Continuing operations
$1.03 $0.83 $2.79 $2.17 
Discontinued operations— (0.01)— (0.01)
Attributable to GE HealthCare common stockholders1.03 0.82 2.79 2.16 
Diluted Earnings Per Share:
Continuing operations
$1.02 $0.83 $2.77 $2.16 
Discontinued operations— (0.01)— (0.01)
Attributable to GE HealthCare common stockholders1.02 0.82 2.77 2.15 
Antidilutive securities(1)
2 4 4 4 
(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.